1. SIX4 , a Potential Therapeutic Target for Estrogen Receptor-Positive Breast Cancer Patients, is Associated with low Promoter Methylation Level
   Hua-Tao Wu et al, 2023, Epigenomics CrossRef
2. IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
   Xin Xu et al, 2022, Materials Today Bio CrossRef
3. Targeting IGF2BP3 in Cancer
   Xin Liu et al, 2023, International Journal of Molecular Sciences CrossRef